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Abstract
Purpose A substantial part (21–35%) of defunctioning stomas created during resection for colorectal cancer will never be
reversed. Known risk factors for non-closure are age, peri- or postoperative complications, comorbidity, and tumor stage.
However, studies performed to identify these risk factors mostly focus on rectal cancer and include both preoperative and
postoperative factors. This study aims to identify preoperative risk factors for non-reversal of intended temporary stomas created
during acute resection of left-sided obstructive colon cancer (LSOCC) with primary anastomosis.
Methods All patients who underwent emergency resection for LSOCC with primary anastomosis and a defunctioning stoma
between 2009 and 2016 were selected from the Dutch ColoRectal Audit, and additional data were collected in the local centers.
Multivariable analysis was performed to identify independent preoperative factors for non-closure of the stoma.
Results A total of 155 patients underwent acute resection for LSOCC with primary anastomosis and a defunctioning stoma. Of
these, 51 patients (32.9%) did not have their stoma reversed after a median of 53 (range 7–104) months of follow-up. In
multivariable analysis, hemoglobin < 7.5 mmol/L (odds ratio (OR) 4.79, 95% confidence interval (95% CI) 1.60–14.38, p =
0.005), estimated glomerular filtration rate (eGFR) ≤ 45 mL/min/1.73 m2 (OR 4.64, 95% CI 1.41–15.10, p = 0.011), and
metastatic disease (OR 6.12, 95% CI 2.35–15.94, p < 0.001) revealed to be independent predictors of non-closure.
Conclusions Anemia, impaired renal function, and metastatic disease at presentation were found to be independent predictors for
non-reversal of intended temporary stomas in patients who underwent acute resection for LSOCC. In patients who have an
increased risk of non-reversal, the surgeon should consider a Hartmann’s procedure.
Keywords Colorectal cancer . Surgical oncology .Stoma reversal .Obstructive colon cancer .Non-closure .Defunctioning stoma
Introduction
Many patients who undergo resection for colorectal cancer, in
particular those with severe comorbidities, neo-adjuvant che-
moradiation, and/or low anastomosis, receive a defunctioning
stoma to reduce the clinical consequences of anastomotic
complications. In the emergency setting and especially in the
case of malignant bowel obstruction, anastomotic healing
might be impaired because of distension of the bowel [1].
For patients with left-sided obstructive colon cancer, the var-
ious treatment modalities are available, including colonic
stenting, diversion with a stoma only or “blowhole,” resection
with end-colostomy, and resection with primary anastomosis
with or without diverting stoma.
In the case of resection with primary anastomosis and a
diverting stoma, most of the stomas created in these circum-
stances are intended to be temporary; however, 21–35% of
these stomas will never be reversed [2, 3]. Generally, these
temporary stomas are loop ileostomies. The morbidity related
to loop ileostomies can be considerable, including a high-
output stoma, causing dehydration and readmission [4].
Since end colostomies are associated with less serious com-
plications, these stomas may be preferred in the subgroup of
patients who have a high risk of non-closure.
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Several studies have been published to identify risk factors
associated with non-closure of stomas that were intended to be
temporary in case of colorectal cancer resection. These risk
factors include age, peri- or postoperative complications, co-
morbidity, and tumor stage [5–8]. However, the majority of
these studies concern data on procedures performed for rectal
cancer. Less is known about risk factors for non-closure of an
intended temporary stoma in the case of (emergency) resec-
tion for (left-sided) colon cancer [9]. Moreover, many studies
focus on postoperative factors as predictors for non-closure of
the stoma, such as anastomotic leakage and other complica-
tions [5], whereas few studies focus on preoperative factors,
which are the only factors that are useful to estimate the pre-
operative risk of non-closure of an intended temporary stoma.
This study aims to identify independent preoperative pre-
dictors for non-closure of an intended temporary
defunctioning stoma that was constructed following emergen-
cy resection for a left-sided obstructive colon cancer (LSOCC)
with primary anastomosis, in order to aid clinical decision-
making and, in addition, to assist informing patients on their
individual probability that their stoma could potentially be
reversed in the future or not.
Methods
Recently, a national collaborative retrospective research pro-
ject has been conducted in the Netherlands by the Dutch
Snapshot Research Group (DSRG). The methodology has
been described in the first publications of this project [10,
11]. In summary, data from all patients in the Netherlands
undergoing resection of primary colorectal cancer are pro-
spectively collected in the Dutch ColoRectal Audit (DCRA).
From the latter, the DSRG selected all patients who underwent
resection for LSOCC, i.e., all patients with a primary tumor
location in the splenic flexure, descending colon, or sigmoid
colon, between 2009 and 2016. Patients were considered to
have acute colonic obstruction when they had both at least one
clinical sign of colonic obstruction (distended abdomen, nau-
sea, and/or vomiting) and radiological signs of colonic ob-
struction on CT (dilated large and/or small bowel loop).
Patients with clinical or radiological signs of perforation were
excluded. Of the included patients, short-term data were ex-
tracted from the DCRA. In addition, contributors from each
participating hospital in the Netherlands were asked to retro-
spectively provide data from individual patient files on their
registered patients with regard to long-term surgical and on-
cological outcomes. These data were entered into an online
tool, following legal privacy regulations. The study was de-
signed and the manuscript prepared in accordance with the
STROBE statement [12]. The medical ethics committee of
the Academic Medical Centre in Amsterdam reviewed and
approved the observational study design, and decided that
informed consent was not needed to be obtained as there
was no additional burden for the patient owing to the obser-
vational design of the study.
Patient selection
For the current analysis, patients who underwent emergency
resection for LSOCC with the construction of a primary anas-
tomosis and defunctioning stomawere selected from the entire
cohort. Patients had either a loop ileostomy or a loop colosto-
my, depending on the surgeon’s preference. If the type of
stoma was unknown, the patient was excluded.
Baseline characteristics including age, sex, type of resec-
tion and stoma type, and location were collected.
Subsequently, patients were subdivided into two groups ac-
cording to whether the intended defunctioning stoma was re-
versed at the end of follow-up or not. A set of preoperative
factors (known prior to acute resection for LSOCC) hypothe-
sized to be of predictive value for non-closure of the
defunctioning stoma was analyzed. These factors included
age; body mass index (BMI); classification of the American
Society of Anesthesiologists (ASA-classification); preopera-
tive laboratory findings including hemoglobin, leukocyte
count, C-reactive protein (CRP), and estimated glomerular
filtration rate (eGFR) using the equation developed from the
Modification of Diet in Renal Disease (MDRD) study [13];
metastatic disease at presentation; and variables regarding du-
ration of symptoms, such as nausea and vomiting, or absence
of stool. Since postoperative factors do not influence intraop-
erative decision-making, these factors were not included.
Statistical analysis
For statistical analysis, IBM Statistical Package for the Social
Sciences (SPSS) version 23 was used. Values were expressed
as means (standard deviation, SD) or medians (range), de-
pending on whether data were normally distributed or not.
To identify independent predictors for non-closure of an
intended temporary stoma, univariable analysis was per-
formed for every individual preoperative variable as described
above by binary logistic regression analysis.
All continuous variables were primarily used as such; how-
ever, only when the distribution showed to be highly skewed,
we chose to categorize these values for analysis. For hemo-
globin, a cutoff value of 7.5 mmol/L was chosen because this
value is often used as the lower limit of a normal hemoglobin.
For CRP, a cutoff value > 10 mg/L was used as this is the
cutoff of CRP in the Glasgow Prognostic Score for predicting
cancer outcomes [14]. An eGFR of 45 mL/min/1.73 m2 was
chosen as cutoff value, as an eGFR < 45 mL/min/1.73 m2
implies a clinically relevant decline in renal function.
All variables with a p value < 0.2 in univariable analysis
were entered together in the multivariable logistic regression
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model. A manual backward stepwise approach was used to
remove non-significant variables; only variables with p values
< 0.05 were kept in the final multivariable model and consid-
ered independent predictors. The odds ratio (OR), 95% confi-
dence interval (CI), and p value were reported for every var-
iable identified as independent predictor for non-closure of an
intended temporary defunctioning stoma.All reported p values




A total of 2404 registered patients underwent emergency re-
section for LSOCC during the study period. Of these patients,
155 patients underwent resection with construction of a pri-
mary anastomosis and defunctioning stoma (Fig. 1); a loop
ileostomy was constructed in 117 patients (75.5%) and a loop
colostomy in 38 patients (25%). The type of resection was a
sigmoidectomy in 87 cases (56%), left hemicolectomy in 31
(20%), subtotal colectomy with ileorectal anastomosis in five
patients (3%), and partial mesorectal excision (PME) for distal
sigmoid colon cancer in 24 patients (16%), and one patient
(1%) underwent resection of the transverse colon for a colon
cancer at the splenic flexure. The remaining 7 patients (5%)
had both a sigmoidectomy and a right hemicolectomy because
of an impending blow-out of the caecum. After a median
follow-up of 53 (range 7–104) months, the stoma was re-
versed in 104 patients (67.1%), whereas this was not reversed
in 51 patients (32.9%). Thirty-seven of the latter were
ileostomies (73%). Baseline characteristics for these two
groups of patients are shown in Table 1.
During presentation, abdominal distension was present in
130 patients (83.9%) and vomiting in 94 (61%), and 22 pa-
tients (14%) reported weight loss. In 122 cases (78.7%), ab-
dominal CT-scan was performed prior to surgery, which
showed distended bowels in 76 patients (64%). Imaging
showed distant metastasis in 27 patients (17%) at presentation.
Predictors for non-closure of stoma
In univariable analysis, hemoglobin < 7.5 mmol/L, CRP >
10 mg/L, eGFR ≤ 45 mL/min/1.73 m2, and metastatic disease
at presentation showed to be significantly correlated with an
increased risk of non-closure of the intended temporary stoma
(Table 2). Age; type of stoma, i.e., ileo- or colostomy; BMI;
ASA-classification; and duration of symptoms were not iden-
tified as significant predictors in univariable analysis.
All variables with p values < 0.2 in univariable analysis,
i.e., ASA-classification, hemoglobin < 7.5 mmol/L, CRP >
10 mg/L, eGFR ≤ 45 mL/min/1.73 m2, and metastatic disease
at presentation, were entered into the multivariable logistic
regression analysis. Only hemoglobin < 7.5 mmol/L (OR
4.79, 95% CI 1.60–14.38, p = 0.005), eGFR ≤ 45 mL/min/
1.73 m2 (OR 4.64, 95% CI 1.41–15.10, p = 0.011), and met-
astatic disease (OR 6.12, 95% CI 2.35–15.94, p < 0.001) were
found to be independent predictors of non-closure of
defunctioning stoma (Table 2).
Discussion
Patients with anemia, impaired renal function and/or metasta-
tic disease at presentation had a significantly higher risk that
their intended temporary defunctioning stoma was not re-
versed after emergency resection for LSOCC with primary
anastomosis. In contrast, the type of temporary stoma, i.e.,
ileo- or colostomy, BMI, sex, age, or ASA-score, did not af-
fect the rate of stoma reversal.
This study revealed a high non-closure rate of
defunctioning stomas as approximately one-third of
defunctioning stomas was not reversed. However, this is com-
parable with the percentages reported in the literature [3]. To
the best of our knowledge, this is the first study identifying
risk factors of non-closure of an intended temporary stoma in
case of LSOCC, and, in addition, the first study only focusing
on preoperative parameters. The results of the current study
can contribute to clinical decision-making in patients whoFig. 1 Flow-chart of patient inclusion
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Male 53 (51.0%) 29 (56.9%)
Female 51 (49.0%) 22 (43.1%)
Age (years)
−50 3 (2.9%) 5 (9.8%)
50–60 22 (21.2%) 6 (11.8%)
60–70 35 (33.7%) 16 (31.4%)
70–80 34 (32.7%) 13 (25.5%)
80+ 10 (9.6%) 11 (21.6%)
BMI (kg/m2) 25 (17–38) 24 (18–40)
BMI ≤ 30 80 (85.1%) 39 (83.0%)
BMI > 30 14 (14.9%) 8 (17.0%)
ASA-classification
ASA 1–2 81 (77.9%) 33 (64.7%)
ASA 3–5 23 (22.1%) 18 (35.3%)
Duration of symptoms prior to presentation (days) 6 (0–173) 5 (0–154)
Preoperative hemoglobin (mmol/L) 8.8 (4.7–11.7) 8.5 (5.2–11.4)
Preoperative leukocyte count (× 109/L) 11.4 (4.1–27.2) 11.1 (4.7–24.0)
Preoperative C-reactive protein (mg/L) 10 (1–239) 22 (1–290)
Preoperative eGFR (mL/min/1.73 m2) 83 (32–154) 76 (12–130)
Clinical M-stage
cM0 92 (91.1%) 32 (64.0%)
cM1 9 (8.9%) 18 (36.0%)
Type of resection
Sigmoidectomy 61 (58.7%) 26 (51.0%)
Left hemicolectomy 20 (19.2%) 11 (21.6%)
Subtotal colectomy 2 (1.9%) 3 (5.9%)
Low anterior resection
(partial mesorectal excision)
18 (17.3%) 6 (11.8%)
Sigmoidectomy + right hemicolectomy 3 (2.9%) 4 (7.8%)
Transverse colon resection 0 (0.0%) 1 (2.0%)
Approach of operation
Open 92 (88.5%) 51 (100.0%)
Laparoscopic 12 (11.5%) 0 (0.0%)
Stoma location
Ileum 80 (76.9%) 37 (72.5%)
Ascending colon 1 (1.0%) 3 (5.9%)
Transverse colon 21 (20.2%) 7 (13.7%)
Descending colon 2 (1.9%) 4 (7.8%)
Pathological tumor stage
pT2 3 (2.9%) 0 (0.0%)
pT3 74 (71.2%) 34 (66.7%)
pT4 27 (26.0%) 17 (33.3%)
pN0 48 (46.2%) 17 (33.3%)
pN1 34 (32.7%) 19 (37.3%)
pN2 22 (21.2%) 15 (29.4%)
Data are given as number of cases (%). Continuous variables were given as median (range)
BMI, body mass index; ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate
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undergo an emergency left-sided colon resection for obstruc-
tion. When one or even more of the identified risk factors for
non-closure are present, the operating surgeon should consider
creating an end-colostomy instead of a primary anastomosis
with loop ileostomy, as the latter has a higher risk of high
output and consequently dehydration which often leads to
readmission [4]. The preoperative presence of these risk fac-
tors can assist in counseling patients about the potential risk of
non-closure of a temporary stoma and in shared decision-
making with regard to the choice of stoma type. In addition,
one can also consider the prevention of an emergency
resection. Initial decompression might prevent postoperative
mortality and non-closure of a stoma, especially in the elderly
patients [2, 15]. Such a bridging strategy can be accomplished
by using a colonic stent or just a defunctioning stoma.
Resection can be scheduled in an elective setting after the
bowel distention has been restored.
A low hemoglobin level and impaired renal function are
both expressions of a poor physical condition and/or a longer
course of the disease. This might explain a four times higher
risk of non-closure of a stoma in patients with one of these risk
factors. Duration of symptoms prior to presentation also










≤ 70 1.00 (reference)





BMI (kg/m2) 0.99 (0.91–1.07) 0.783
ASA-classification
0.083
ASA 1–2 1.00 (reference)
ASA 3–5 1.92 (0.92–4.02)





> 7.5 mmol/L 1.00 (reference) 1.00 (reference)
< 7.5 mmol/L 2.96 (1.14–7.72) 4.79 (1.60–14.38)
Preoperative leukocyte count (× 109/L) 0.99 (0.91–1.07) 0.736
Preoperative C-reactive protein
0.014 NS
≤ 10 mg/L 1.00 (reference)
> 10 mg/L 2.53 (1.28–5.31)
Preoperative eGFR
0.022 0.011
> 45 mL/min/1.73 m2 1.00 (reference) 1.00 (reference)
≤ 45 mL/min/1.73 m2 3.62 (1.21–10.84) 4.64 (1.41–15.10)
Clinical M-stage
< 0.001 < 0.001
cM0 1.00 (reference) 1.00 (reference)





OR (95%CI), odds ratio (95% confidence interval); BMI, bodymass index; eGFR, estimated glomerular filtration
rate; NS, not significant; ASA, American Society of Anesthesiologists
The significant p-values in uni- and multivariable analysis are highlighted in italic
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provides information about the length of disease. Therefore, we
also expected this variable to be significantly associated with a
lower stoma reversal rate. However, duration of symptoms was
not identified as an independent predictor of non-closure of the
stoma in the current study. The reason for this might be the
unreliably reporting of this factor as a result of the retrospective
design of the study. In addition, symptoms usually develop
gradually and duration of symptoms is a subjective measure-
ment obtained from patients in an acute phase of their disease.
Metastatic disease at presentation was associated with a six
times higher risk of non-closure of the stoma. This could at least
partly be explained by a shorter survival of patients with stage
IV disease. Furthermore, patients with metastatic disease often
undergo systemic therapy that interferes with surgical interven-
tions, patients might be less motivated to have their stoma re-
versed due to the associated risks of surgery during systemic
therapy, and surgeons might be less willing to reverse the stoma
in the palliative setting. In addition, one should avoid an
ileostomy and consider performing a Hartmann’s procedure in
the case of metastatic disease, as chemotherapy could lead to
high stoma output in patients with an ileostomy.
Other factors that are normally taken into account when
choosing between a defunctioning stoma and end-colostomy,
such as age and ASA-score, were not identified as indepen-
dent predictors of non-closure of the stoma in the current
study. Therefore, it seems not justifiable to base one’s decision
on these factors, despite the fact that previous studies have
shown age to be a predictive factor for non-reversal of a
defunctioning stoma in rectal cancer surgery [9]. In addition,
BMI was also not found to be associated with non-closure of
the stoma in this study, despite our clinical impression that
patients with obesity generally have a more complicated post-
operative course and therefore are less likely to have their
stoma reversed. This might be well explained by the relatively
low number of patients with obesity in this cohort.
Previous studies reported complications from index sur-
gery to be significantly associated with non-closure of stoma
[8, 9]. However, this is only known after the index surgery,
whereas the decision of creating a stoma is taken before or
during surgery. We therefore only focused on preoperative
variables in the current study. Moreover, previous studies
mainly focused on surgery for rectal cancer; none of these
studies concerns colon cancer.
The current study has some limitations. First, the study
design was retrospective, incorporating the risk of bias as well
as some missing data, although the latter was limited for the
included study population; for hemoglobin, 3.2% of the data
was missing, for eGFR 4.5% and for CRP 7.1%. In 2.6% of
patients, it was unknown whether they had metastasis at pre-
sentation or not. Although a prospective study design would
be preferable, the current study design enabled us to collect a
relatively large cohort of patients from a representative variety
of hospitals, which is important as emergency left-sided colon
resection with primary anastomosis and a defunctioning stoma
is relatively rare. In addition, oncological follow-up regarding
local recurrence or metachronic metastasis has not been taken
into account in this analysis, whereas this might be an impor-
tant factor in the (postoperative) decision whether to reverse a
stoma or not. Lastly, intraoperative findings such as peritoni-
tis, bowel perfusion, or advanced tumor stage could strength-
en or weaken the model that estimates the risk of non-reversal
in the current study. However, due to the retrospective design,
these intraoperative data were not available for analysis in the
current study.
In conclusion, hemoglobin < 7.5 mmol/L, eGFR ≤ 45 mL/
min/1.73 m2, and metastatic disease at presentation were
found to be independent preoperative predictors for non-
closure of an intended temporary defunctioning stoma created
during acute resection for left-sided obstructive colon cancer
with primary anastomosis. These findings might support clin-
ical decision-making on the type of stoma creation and might
assist informing patients on their individual probability that
their stoma could potentially be reversed in the future or not.
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